On February 19th, according to the announcement from the China National Intellectual Property Administration, SCITOP BIO-TECH applied for a patent titled “Compound Probiotic and Postbiotic Compositions for Improving or Treating Skin Allergies”, with the publication number CN117547559A and the application date of November 2023. This invention’s formula consists of Lactobacillus paracasei ProSci-101 (CGMCC No.26528) and fermented Lactobacillus ProSci-602 (CGMCC No.25451). This product can be used to improve or treat skin allergies, reduce skin sensitization, enhance the skin’s resistance to bacterial infections, and promote skin barrier repair. There are no reported side effects such as dizziness, nausea, or loss of appetite. (Source: baijiahao)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE